SCHEMBL4743831

SCHEMBL4743831

CC([CH]C(=O)NCc1ccccc1)C(N)=O

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.58
CYP2D6 P10635 2/20 0.58
CYP2C19 P33261 2/20 0.58
LMNA P02545 2/20 0.58
CYP2C9 P11712 2/20 0.54
KMT2A Q03164 3/20 0.51
MAPT P10636 2/20 0.51
MMP1 P03956 2/20 0.51
MMP2 P08253 2/20 0.51
MMP9 P14780 2/20 0.51
MEN1 O00255 2/20 0.51
L3MBTL1 Q9Y468 2/20 0.50
SMN1; SMN2 Q16637 3/20 0.49
TAAR1 Q96RJ0 1/20 0.48
CYP1A2 P05177 1/20 0.47
TSHR P16473 1/20 0.47
HPGD P15428 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4746745 1.00 ALDH1A1 (0.58) ALDH1A1CYP2D6CYP2C19LMNACYP2C9
SCHEMBL4746606 0.84 ALDH1A1 (0.51) ALDH1A1CYP2D6CYP2C19LMNACYP2C9
SCHEMBL3240744 0.84 ALDH1A1 (0.55) ALDH1A1LMNAMAPTSMN1; SMN2
SCHEMBL4747913 0.83 RECQL (0.62) ALDH1A1CYP2C19LMNACYP2C9KMT2A
SCHEMBL17152612 0.80 ALDH1A1 (0.50) ALDH1A1CYP2D6CYP2C19LMNACYP2C9
SCHEMBL4749373 0.79 ALDH1A1 (0.49) ALDH1A1CYP2D6CYP2C19LMNACYP2C9
SCHEMBL1185095 0.77 ALDH1A1 (0.67) ALDH1A1CYP2D6CYP2C19LMNACYP2C9
SCHEMBL7993179 0.77 KMT2A (0.69) ALDH1A1CYP2D6CYP2C19CYP2C9KMT2A
SCHEMBL13956776 0.77 CYP2C9 (0.71) ALDH1A1CYP2D6CYP2C19LMNACYP2C9
SCHEMBL2353189 0.76 ALDH1A1 (0.61) ALDH1A1CYP2D6CYP2C19LMNACYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008119772-A1 AMIDE DERIVATIVES AS INHIBITORS OF ASPARTYL PROTEASES MEDIVIR AB (SE) 2008-10-09 WO disclosed
WO-2008107365-A1 NEW COMPOUNDS MEDIVIR AB (SE) 2008-09-12 WO disclosed